Selective induction of interleukin‐1 receptor antagonist and interleukin‐8 in human monocytes by normal polyspecific IgG (intravenous immunoglobulin)
- 1 May 1995
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 25 (5) , 1267-1273
- https://doi.org/10.1002/eji.1830250521
Abstract
We have investigated the effects of intravenous immunoglobulin (IVIg), a therapeutic preparation of normal human polyspecific IgG, on the synthesis and release of cytokines by peripheral blood monocytes. IVIg was found to selectively induce gene transcription and secretion of interleukin‐1 receptor antagonist (IL‐1ra) and IL‐8 in cultures of normal human monocytes. The addition of IVIg to cultures of purified monocytes induced a dose‐dependent secretion of IL‐1ra and IL‐8 without stimulating the production of IL‐1α, IL‐1β, tumor necrosis factor‐α or IL‐6. The effects of IVIg required both the Fc and F(ab′)2 portions of IgG. IVIg‐induced production of IL‐8 by monocytes was enhanced by lipopolysaccharide (LPS), although LPS inhibited the secretion of IL‐1ra, suggesting that IVIg and LPS stimulate distinct intracellular pathways in monocytes. Induction of IL‐1ra and IL‐8 by IVIg was enhanced in the presence of autologous T lymphocytes. Our observations document the selectivity of the effects of IVIg on the synthesis of cytokines and cytokine antagonists by human monocytes. Induction of IL‐1ra and IL‐8 by IVIg may contribute to the anti‐inflammatory effects of immunoglobulin therapy in patients with autoimmune and systemic inflammatory disorders.Keywords
This publication has 35 references indexed in Scilit:
- Lymphokine production induced by streptococcal pyrogenic exotoxin‐A is selectively down‐regulated by pooled human IgGEuropean Journal of Immunology, 1994
- Endotoxin tolerance is not a LPS-specific phenomenon: partial mimicry with IL-1, IL-10 and TGFβInnate Immunity, 1994
- Infusion of Fcγ fragments for treatment of children with acute immune thrombocytopenic purpuraThe Lancet, 1993
- Membrane molecules which trigger the production of interleukin‐1 and tumor necrosis factor‐α by lipopolysaccharide‐stimulated human monocytesEuropean Journal of Immunology, 1992
- Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitroImmunology Today, 1991
- Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonistNature, 1990
- Mechanism of therapeutic effect of high-dose intravenous immunoglobulin. Attenuation of acute, complement-dependent immune damage in a guinea pig model.Journal of Clinical Investigation, 1989
- Human T cells and interleukin 4 inhibit the release of interleukin 1 induced by lipopolysaccharide in serumfree cultures of autologous monocytesEuropean Journal of Immunology, 1989
- In vivo induction of interleukin-1 during hemodialysisKidney International, 1989
- Transient Reversal of Thrombocytopenia in Idiopathic Thrombocytopenic Purpura by High-Dose Intravenous Gamma GlobulinNew England Journal of Medicine, 1982